Froome exceeds legal limit of asthma drug

PARIS — Chris Froome failed a doping test during the Spanish Vuelta in September and is facing a suspension from cycling ahead of his attempt to win a record-equaling fifth Tour de France title next year.

Froome won his fourth Tour title this year and followed it with a victory at the Vuelta. But Team Sky said Wednesday that Froome, who has not been suspended, had a concentration of asthma drug salbutamol two times higher than the World Anti-Doping Agency’s permitted levels.

“Analysis indicated the presence of salbutamol at a concentration of 2,000 nanograms per milliliter (ng/ml), compared with the WADA threshold of 1,000 ng/ml,” Team Sky said .

Team Sky said it has been informed by the International Cycling Union that the urine test was taken on Sept. 7, during the three-week Spanish Vuelta.

Froome said the UCI has asked him to provide information about the failed test, which was taken after Stage 18.

Froome’s use of asthma medication has been well documented, and the Kenyan-born rider has often been spotted using inhalers in the peloton. He has repeatedly faced questions on whether he is a clean rider, especially during the Tour de France, and has always denied wrongdoing.

“I can understand a lot of people’s reactions, especially given the history of the sport. This is not a positive test,” Froome said in an interview aired by British broadcasters on Wednesday. AP